CBD and its various forms are slowly taking over the healthcare industry. Looking at its increased acceptance, variety of medicinal uses and legalization, the chances of CBD replacing big pharmaceutical drugs like gabapentin as an alternate medicine are on the rise.
However, whether or not this replacement is a safer alternative will require to withstand the test of time and further research by experts. Here are some of the facts on the efficacy of both gabapentin and CBD for treating ailments, particularly neuropathy and epilepsy, as per the conclusions of latest studies.
What is gabapentin?
Gabapentin is a prescription drug that is referred by healthcare professionals to treat seizures and epilepsy. The drug also has various background benefits which include providing relief from the debilitating symptoms of nephropathy and migraines.
Despite of all of these acclaimed health benefits, gabapentin has come under immense scrutiny of experts due to its side-effects on the body. Abnormal eye movements, difficulty speaking, and tiredness are just a few examples of the negative impacts this drug can have on its users. It can also have some severe side-effects on people with underlying conditions. These include irritability, aggressiveness, depression and many other psychiatric disorders.
Clinical lab results released by Quest Diagnostics have revealed that the gabapentin can cause possible addiction as well. The misuse of the drug had been on a raise between the years 2016 and 2017. According to the research findings of Quest Diagnostics, “Individuals taking prescription opioids and gabapentin concomitantly have a 49% greater risk for opioid-related death than those treated with opioids only,” This means that gabapentin can potentially increase the effects of opioids in addition to causing addiction.
Is CBD addictive?
Contrary to this, CBD is emerging as an alternate treatment for various physiological conditions. These conditions range from neuropathy to seizures, and have shown marked improvements after patients administered CBD for relief.
Because of a lack of researches into the side-effects associated with CBD usage, there are chances of a shift towards it as a substitute for prescription medications, including gabapentin.
According to a report by WHO, ” In humans, CBD exhibits no effects indicative of any abuse or dependence potential…. To date, there is no evidence of public health related problems associated with the use of pure CBD.”
The dependence potential of CBD is almost non-existent because it is a non-psychoactive cannabinoid. THC, a close relative of CBD is a cannabinoid that causes the euphoric sensation. In fact, CBD can possibly block THC’s access to the body’s receptors, filtering out some of the psychoactive impacts it has on the body.
CBD as an alternate medicine
Derived from the hemp plant, CBD is a naturally occurring chemical compound. Its chemical structure is very similar to the cannabinoid receptors found in the human body, allowing it to bind effectively with them.
Cannabinoid receptors are located throughout the body and play a vital role in regulating appetite, pain sensation, mood and memory. CBD is an external source of these cannabinoids, and its chemistry helps it to provide unrivaled relief for a variety of symptoms and conditions.
Cannabinoids produced by CBD bind to receptor sites throughout the body. The effect that follows this chemical activity depends upon the receptor sites that cannabinoids end up attaching themselves to.
The cannabis plant contains at least 85 types of cannabinoids on average. Depending on their chemical structure, all of these cannabinoids have some explicit have medicinal benefits on the body. Due to this, many cannabinoids have been synthesized for legal prescription use. Some examples of synthetic cannabinoid medications include Marinol, Nabilone, and Rimonabant.
All of these medications are non-addictive and do not alter the heart rate, blood pressure, or body temperature of the patients.
Evidence of health benefits of cannabidiol (CBD)
There is a significant amount of research to back the health benefits of CBD. Out of these evidences, perhaps the most solid attestation comes from the ability of CBD to treat the cruelest childhood epilepsy syndromes.
CBD compounds effect communication networks of the brain and allegedly slow down message transfer towards the brain. It changes calcium levels in brain cells and decreases any inflammation therein, reducing seizures tremendously.
Sighting these success stories and evidences, FDA has recently approved the first ever CBD based epilepsy medicine called Epidiolex.
CBD vs Pharmaceutical Drugs
In 2017 a research was conducted by Brightfield Group to gauge effectiveness of cannabis as an alternate medicine. The research was based on 2400 individuals who were registered users of a cannabis advocacy website, HelloMD.
The findings of the research showed that 42% of CBD users had given up on pharmaceutical drugs. About 52% of the participants found CBD to be more effective in providing them relief from their ailments.
Medical conditions like epilepsy and neuropathy can leave individuals complexly dependent upon others.
Before trying on any treatment option out of desperation, it is always a good idea to consult healthcare physicians. This will help to rule out any chances of drug interactions or probable side-effects from affecting patients.
The effectiveness of CBD based products is a relatively new development in the healthcare department. Its long-term side-effects are yet to be researched. Therefore, expert consultation before picking up any treatment option is an absolute necessity.
Texas Med Store Starts Selling Cannabis-Infused Gummies As Medical Marijuana
As more and more states legalize cannabis use, dispensaries are finding new ways to morph cannabis into daily-use things. The popularity of medical marijuana is undoubtedly off the charts. In another of such events, one of the state’s dispensaries now offers medical marijuana-infused gummies.
The Lone Star state is the second largest of all the states, falling behind Alaska. The fact that Elon Musk has set up his residence in the state has made it even more popular. Surterra Wellness, a well-known Florida-based marijuana company, is also operating in Texas. with a dispensary in Austin — launched its line of Surterra Wellness is bringing cannabis-infused lineup of edibles to cater to the needs of patients and cannabis consumers alike. This will provide patients with THC in a less intimidating form. The president of Surterra Wellness is positive about the impact this lineup of edibles can have.
Gummy Bears Carrying Marijuana
Mr. Ruark, the Surterra Wellness president, believes that the popularity of gummies makes them ideal to administer medicinal marijuana. Gummies are by far the most popular dosing form in medical markets across the United States. In addition to the popularity of gummies, they also contain terpenes. Terpenes provide a plethora of therapeutic properties and is an all natural extract.
They also give medical marijuana users a new way of ingesting THC. The many flavors that gummy bears are available, make it a great option to use for the deliverance of medical marijuana.
Medicinal marijuana, although legal in Texas, is under extreme regulation and restrictions. Residents must opt into the Texas Compassionate Use Program that allows subscribers to use cannabis products for medicinal purposes. This programme was created in 2015 and is caters to patients of medical conditions such as epilepsy, seizures, terminal cancer, multiple sclerosis, incurable neurological disorders, autism and ALS.
Now, with the advancements in the way marijuana is covering ground, cannabis advocates in Texas are pressuring legislators to expand the program. There are expectations that the expansion will include patients suffering from PTSD.
Ruark believes that people are largely unaware of the medicinal programme in Texas. Also, he believes these gummies will change this. He thinks that his company can raise awareness about the state’s medical marijuana program.
Increasing The Cannabis Family by 2 Million
Increased reach will allow two million patients to use it who qualify for it even now but don’t use it because they don’t know about the program.
The president of the dispensaries wants everyone to benefit from the nature’s gift. He wants everyone to reap the benefits of cannabis. It may be of special benefit for veterans in dealing with PTSD after their return back to a normal life.
These lovely gummy treats come in a bottle that costs $60 and contains 200 milligrams of THC in total.
Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases
The cannabis plant contains multiple components of varying benefits, of which some constituents are psychoactive while others are non-psychoactive and have other pharmacological impacts. Because of the pharmacological benefits, researchers are working to formulate cannabis antibiotics.
According to the research of The University of Queensland, CBD is a component present in marijuana, is non-psychoactive, and is capable of killing bacteria. It is useable in antibiotics due to its ability to kill bacteria responsible for gonorrhea, meningitis, and legionnaires.
Moreover, according to studies, there is a possibility that drug-resistance diseases can cause more than 10 million deaths per year by 2050. The UN warns that there is an urgent need to deal with drug-resistant illnesses. Furthermore, finding solutions to the problems of drug resistance must be of utmost priority.
Drug resistance is growing, leading to critical problems shortly. According to neurologists, within five years, the NHS will successfully develop effective cannabis-antibiotics. Moreover, the treatment of drug-resistant diseases will be possible with the use of this marijuana containing antibiotics.
Cannabis In Antibiotics
CBD is the cannabidiol, a major non-psychoactive and second-most prevalent component of the active ingredients of marijuana. Two institutions researched using cannabis in antibiotics. The institutions that collaborate for research are the University of Queensland and Botanix Pharmaceuticals Limited.
In their research, researchers examined how the CBD of cannabis penetrates through the protective membranes of multiple bacteria. Moreover, not only does the CBD enter the bacteria, but it also kills them.
Of the bacteria through which CBD penetrates are bacteria for meningitis, legionella, and Neisseria gonorrhea. The legionella bacteria cause legionnaire’s disease characterized by cough, shortness of breath, high fever, muscle pain, nausea, vomiting, and headache.
The researchers found that CBD was able to break down the biofilm of the bacteria. Biofilm is a slimy build-up of bacteria released by it to survive against antibiotic treatment. Moreover, the biofilm’s slimy layer is similar to a dental plaque on the surface.
What Is In The Future For Cannabis?
Cannabis-infused antibiotics may be available in the market. According to Professor Mike Barnes, pretty-soon general practitioners will start prescribing CBD pills to treat infectious diseases. Research on marijuana is progressing fast. Moreover, there are chances of formulating much better cannabis products for medicinal use.
According to Mike Barnes, it is high time that individuals understand the medical benefits of marijuana and take advantage of the plant to its full capacity. Moreover, the marijuana plant is useable in various ways to improve the condition of patients.
The new research led by the University of Queensland and Botanix Pharmaceutical Limited is helpful in the subject. However, further research is vital for developing much better, safer, and effective drugs containing CBD of marijuana.
More Studies Essential For A Better Future
According to Professor Mike Barnes, if CBD is placed next to bacteria in a plate, the cannabidiol will kill the bacteria right away. However, if a tablet containing CBD is on the same plate as the bacteria, the effect of CBD will be slower.
The professor is confident that with further research on the subject, better medicine formulation can occur for treating drug-resistant diseases. Moreover, UK regulators can formulate something that can fight against antibiotic-resistant gonorrhea. Furthermore, the formation of antibiotics for drug-resistant gonorrhea is the utmost priority of the World Health Organization.
Once the formulation of the cannabis-containing antibiotics is complete, the drugs will need the approval to conduct preclinical-trials and clinical trials. After completing the clinical trials and research investigations, the authorities will consider the drugs for approval after which they will be available in the market.
Deep studies and research investigations enable the formulation of a more effective formulation. The quicker the cannabis containing antibiotics gets approval, the sooner they will be in the market for treating drug-resistant bacterial diseases.
International Market For Marijuana-Infused Drinks On The Rise
The international market for marijuana products, especially marijuana-infused alcoholic drinks, is rising. Agreements and contracts or partnerships are being made globally to expand the cannabis industry and facilitate a larger number of clients.
Individuals like to use alcoholic drinks containing marijuana for recreational purposes. Such drinks enable them to have fun, enjoy themselves in their own company and be themselves. Moreover, alcoholic drinks with cannabis enable individuals to get rid of a stressful situation.
Some of the best cannabis-containing drinks include CBD-Enriched Ales, Cherry CBD Cocktails, CBD-Infused Bloody Mary Mixes, and Inaugural Sparkling Cannabis Wines. In addition, individuals can try CBD Cocktail Bitters, CBD-Infused Hemp Rums, Cannabis-Based Beers, Vegan Cannabis Wines, Marijuana-Infused IPAs, CBD-Infused Cocktail Bars and THC-Infused Beers.
Some more weed-containing drinks include Cannabis-Infused Beers, Cannabis Oil-Infused Beers, Adaptogenic Non-toxicating Cocktails, All-Natural Social Tonics, and CBD-infused Green Wines. Some drinks contain marijuana but are non-alcoholic, and others have alcohol in them. However, their selection entirely depends upon individuals’ tastes and choices. But customer choice determines the sale of the product and its market value. Understanding the market and product value is essential to run a successful business.
The Study About Marijuana-Infused Alcoholic Drinks
Research regarding the marijuana-infused alcoholic drink market highlights the latest trends in the industry. However, the study also mentions the breakdown of marijuana products and services. Furthermore, the report elaborates on factors that affect the sales of drinkable cannabis products. It elaborates on the market status, size, share, and growth factors relating to one another.
Moreover, the research gathers data from primary interviews and in-house expert reviews. The study explained the effects of the coronavirus-pandemic on sales, demand, production, and the overall market.
Various companies are conducting the international business of marijuana-infused drinks. Some of the big names are COALITION BREWING (USA), Heineken (Netherlands), Klosterbrauerei WeiAYenohe (Germany), and Rodnik (Russia).
The report on the Marijuana-Infused Alcoholic Drink Market gives an estimation of the increase in the growth rate of drinks. Moreover, it predicts the growth rate for the next 5 to 6 years by analyzing the progress of cannabis-infused alcoholic drinkables in the market.
Furthermore, the research analysis includes monitoring and estimating market size, product/ service demand and production, SWOT of providers, and every minute detail about strategies alterations or developments in the marijuana industry.
Types Of Alcoholic Drinks And Their Selling Method
Multiple marijuana industries provide alcoholic drinks containing marijuana. Alcoholic beverages containing cannabis include cannabis-infused beers, weed-containing spirits, and cannabis-containing wines.
Marijuana-containing alcoholic drinks are sellable online and offline means. The market for alcoholic-drinks containing weed is present in North America, Latin America, Middle East, Asia-Pacific, Africa, and Europe. Sales occur in a clear, concise, and professional manner. The report regarding the market of weed drinks gives details and graphical presentations of facts and figures.
By viewing the report, individuals can understand the market strategy, evolution, and progress. Moreover, details about each type of alcoholic drink containing marijuana are in the analytical-report.
What Can An Individual Know From This Report?
The report contains information regarding every R&D plan and M&A. Moreover, it mentions the collaborations made on a global and national platform. Furthermore, individuals can find collective data about CAGR, gross margin, regional price, revenue, and much more regarding alcoholic drinks containing marijuana.
By studying the research analysis, individuals will be able to understand the scope of the market. Moreover, the report uses various analytical tools for the collection and analysis of data. The analytical tools include Porter’s five-force analysis, feasibility study, SWOT analysis, and ROI analysis.
Furthermore, individuals can learn about the major and minor business owners and their progress. Additionally, information regarding each alcoholic drink containing marijuana is available in the report of the Cannabis-Infused Alcoholic Drinks. Knowing about the potential benefits and risk factors of the cannabis industry, particularly matters of marijuana containing alcoholic drinks, enables individuals to do better in their business.
Cannabis2 years ago
How CBD oil works?
Cannabis2 years ago
Research Suggests Cannabis Effective in Treating Endometriosis
Health1 year ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Cannabis2 years ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Featured2 years ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Cannabis2 years ago
What are the main advantages of consuming CBD oil?
Health1 year ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Cannabis1 year ago
Can Cannabis Survive in Pharma?